Data Catalog

GNA NOW

Novel Gram-negative antibiotic now

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

Start: 2019-07-01
Project website

Impentri

Development of Impentri, an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS)

Keywords: IMI projects Respiratory diseases Infectious diseases Coronaviruses Conducting clinical trials

Start: 2020-07-01
Project website

ND4BB

New Drugs for Bad Bugs. Umbrella programme comprising the IMI projects TRANSLOCATION, ENABLE, COMBACTE-NET, COMBACTE-CARE, COMBACTE-MAGNET, COMBACTE-CDI, iABC and DRIVE-AB

Keywords: IMI projects Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Clinical networks Real-world data, evidence Drug discovery Economic model

Project website

PERISCOPE

PERtussIS COrrelates of Protection Europe

Keywords: IMI projects Infectious diseases Vaccines Conducting clinical trials

Start: 2016-03-01
Project website

RespiriNTM

Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials Target identification

Start: 2019-05-01
Project website

RespiriTB

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

Start: 2019-05-01
Project website

TRIC-TB

Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials